Results 231 to 240 of about 146,670 (267)
Some of the next articles are maybe not open access.
Wiener klinische Wochenschrift, 1983
This paper attempts to review current opinions on medullary thyroid carcinoma. Histologically described for the first time in 1951 belongs to the endocrine-secreting group of tumours (APUD). It can be sporadic as well as hereditary. The histological classification nowadays is increasingly performed immunohistologically via calcitonin.
K, Keminger, R, Kokoschka, E, Schmalzer
openaire +1 more source
This paper attempts to review current opinions on medullary thyroid carcinoma. Histologically described for the first time in 1951 belongs to the endocrine-secreting group of tumours (APUD). It can be sporadic as well as hereditary. The histological classification nowadays is increasingly performed immunohistologically via calcitonin.
K, Keminger, R, Kokoschka, E, Schmalzer
openaire +1 more source
Other markers of medullary thyroid cancer, not only calcitonin.
European Journal of Endocrinology, 2023S. Censi, J. Manso, C. Mian
semanticscholar +1 more source
2019
Medullary thyroid cancer is very rare since it represents about 0.2% of all human tumors. It can be sporadic (75%) or familial (25%), and in both cases the pathogenesis is related to the presence of activating mutations of RET oncogene at somatic or germline level, respectively.
Rossella Elisei, Cristina Romei
openaire +1 more source
Medullary thyroid cancer is very rare since it represents about 0.2% of all human tumors. It can be sporadic (75%) or familial (25%), and in both cases the pathogenesis is related to the presence of activating mutations of RET oncogene at somatic or germline level, respectively.
Rossella Elisei, Cristina Romei
openaire +1 more source
Update on Medullary Thyroid Cancer
Endocrinology and Metabolism Clinics of North America, 2014Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer, demonstrating variable behavior from indolent disease to highly aggressive, progressive disease. There are distinguishing phenotypic features of sporadic and hereditary MTC. Activation or overexpression of cell surface receptors and up-regulation of intracellular signaling pathways in ...
Mimi I, Hu +2 more
openaire +2 more sources
Journal of the American Medical Association (JAMA)
Importance Approximately 43 720 new cases of thyroid carcinoma are expected to be diagnosed in 2023 in the US. Five-year relative survival is approximately 98.5%.
Laura Boucai, M. Zafereo, M. Cabanillas
semanticscholar +1 more source
Importance Approximately 43 720 new cases of thyroid carcinoma are expected to be diagnosed in 2023 in the US. Five-year relative survival is approximately 98.5%.
Laura Boucai, M. Zafereo, M. Cabanillas
semanticscholar +1 more source
Hereditary Non‐medullary Thyroid Cancer
World Journal of Surgery, 2007AbstractAn estimated 5% of all non‐medullary thyroid cancers are hereditary. If three or more first‐degree relatives are affected, there is a greater than 94% chance that these cases are hereditary non‐medullary thyroid cancer (HNMTC). Although, the susceptibility gene(s) for HNMTC has not been identified, there are enough epidemiologic studies and ...
openaire +2 more sources
2017
Sažeti prikaz nastanka, kliničke slike, dijagnosticiranja i liječenja medularnog karcinoma štitne žlijezde.
Kusić, Zvonko +7 more
openaire +1 more source
Sažeti prikaz nastanka, kliničke slike, dijagnosticiranja i liječenja medularnog karcinoma štitne žlijezde.
Kusić, Zvonko +7 more
openaire +1 more source
Familial Non-medullary Thyroid Cancer
2018Approximately 3–9% of all nonmedullary thyroid cancers are familial. Familial nonmedullary thyroid cancer (FNMTC) may occur as part of a familial cancer syndrome (syndromic) or as the predominant or only feature being nonmedullary thyroid cancer (nonsyndromic).
Joanna Klubo-Gwiezdzinska +3 more
openaire +1 more source
Familial Non Medullary Thyroid Cancer*
European Surgery-Acta Chirurgica Austriaca, 2002When one thinks about patients with familial thyroid cancer, one usually considers familial medullary thyroid cancer or perhaps familial thyroid cancers associated with familial polyposis or Cowden’s syndromes. However, there have been an increasing number of articles regarding patients with FNMTC in the past few years [1-16].
openaire +1 more source